Search tool

Because the drug phenomenon, its causes and consequences are both complex and serious an evaluation of policy is particularly useful in this field. In permitting a reasoned value judgement of the effects...

Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. The newsletter aims to offer a complete overview of the work of the Agency and...

The EMCDDA 2004 work programme is the first phase of the 2004–06 programme. In particular, it aims to meet the challenge of integrating the new Member States into the EMCDDA's structures and...

The EMCDDA 2004–06 work programme, adopted by the Management Board, aims to consolidate and develop the EMCDDA’s achievements while facing the challenge of EU enlargement cope with relevant EU priorities and any...

In accordance with Article 76 of the Financial Regulation applicable to the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction), the accounts of the EMCDDA shall comprise: "The financial statements of...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...

Commissioned each year by the EMCDDA and produced by the national focal points of the Reitox network, the National reports draw an overall picture of the drug phenomenon at national level in...